Tag: Lecanemab
-
New Blood Test Shows 95% Accuracy in Detecting Key Alzheimer’s Biomarker, Promising Early Diagnosis and Treatment Opportunities
A recent study indicates that a simple blood test could dramatically change the diagnosis of Alzheimer’s disease by detecting key biomarkers with high accuracy. This could lead to early detection and significantly impact the treatment and management of the disease, especially with new drugs on the horizon that are most effective in the early stages.…